Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren’s syndrome

Horino, Taro; Yoshida, Mitsuharu; Inotani, Satoshi; Anabuki, Kazuki; Ohnishi, Hiroshi; Komori, Masahiro; Ichii, Osamu; Terada, Yoshio

doi:10.2478/rjim-2022-0003

Abstract

A 58-year-old woman with a history of Sjogren’s syndrome was admitted to our hospital with cough, decreased right lung breath sounds and arthralgia in both thumbs. Chest computed tomography showed consolidation with air bronchogram in the right lung. Levels of anti-cyclic citrullinated peptide antibody and rheumatoid factor levels were significantly elevated. She was diagnosed with rheumatoid arthritis induced by bacterial organizing pneumonia. Treatment with salazosulfapyridine was added for rheumatoid arthritis and arthralgia gradually improved. This case highlights that respiratory infections could lead to anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis in patients with Sjogren’s syndrome.

References

1. VITALI C., BOMBARDIERI S., JONSSON R., MOUTSOPOULOS HM., ALEXANDER EL., CARSONS SE., et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–8.10.1136/ard.61.6.554175413712006334
Search in Google Scholar Back to article
2. ALANI H., HENTY JR., THOMPSON NL., JURY E., CIURTIN C. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren’s syndrome (secondary Sjögren’s syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol. 2018;47(2):141–54.10.1080/03009742.2017.132490928927315
Search in Google Scholar Back to article
3. BROWN LE., FRITS ML., IANNACCONE CK., WEINBLATT ME., SHADICK NA., LIAO KP. Clinical characteristics of RA patients with secondary SS and association with joint damage. Rheumatology (Oxford). 2015;54(5):816–20.10.1093/rheumatology/keu400441608325313147
Search in Google Scholar Back to article
4. KIM SM., PARK E., LEE JH., LEE SH., KIM HR. The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjögren syndrome. Rheumatol Int. 2012;32(12):3963–7.10.1007/s00296-011-2274-322205381
Search in Google Scholar Back to article
5. LEE J., KOH JH., KIM JW., SUNG YK., LEE SS., CHOE JY., et al. Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren’s syndrome in a Korean cohort. Rheumatol Int. 2018;38(9):1651–60.10.1007/s00296-018-4109-y30030624
Search in Google Scholar Back to article
6. TEN BRINCK RM., VAN STEENBERGEN HW., VAN DELFT MAM., VERHEUL MK., TOES REM., TROUW LA., et al. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia. Rheumatology (Oxford). 2017;56(12):2145–53.10.1093/rheumatology/kex340670399728968865
Search in Google Scholar Back to article
7. NISHIMURA K., SUGIYAMA D., KOGATA Y., TSUJI G., NAKAZAWA T., KAWANO S., et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146(11):797–808.10.7326/0003-4819-146-11-200706050-0000817548411
Search in Google Scholar Back to article
8. PERRY E., KELLY C., EGGLETON P., DE SOYZA A., HUTCHINSON D. The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury? Rheumatology (Oxford). 2014;53(11):1940–50.10.1093/rheumatology/keu19524831057
Search in Google Scholar Back to article
9. LAPPIN DF., APATZIDOU D., QUIRKE AM., OLIVER-BELL J., BUTCHER JP., KINANE DF., et al. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J Clin Periodontol. 2013;40(10):907–15.10.1111/jcpe.1213823902301
Search in Google Scholar Back to article
10. MARESZ KJ., HELLVARD A., SROKA A., ADAMOWICZ K., BIELECKA E., KOZIEL J., et al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog. 2013;9(9):e1003627.10.1371/journal.ppat.1003627377190224068934
Search in Google Scholar Back to article
11. HUTCHINSON D., SHEPSTONE L., MOOTS R., LEAR JT., LYNCH MP. Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Ann Rheum Dis. 2001;60(3):223–7.10.1136/ard.60.3.223
Search in Google Scholar Back to article
12. KALLBERG H., DING B., PADYUKOV L., BENGTSSON C., RONNELID J., KLARESKOG L., et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis. 2011;70(3):508–11.10.1136/ard.2009.120899
Search in Google Scholar Back to article
13. MAKRYGIANNAKIS D., HERMANSSON M., ULFGREN AK., NICHOLAS AP., ZENDMAN AJ., EKLUND A., et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008;67(10):1488–92.10.1136/ard.2007.075192
Search in Google Scholar Back to article
14. KLARESKOG L., STOLT P., LUNDBERG K., KALLBERG H., BENGTSSON C., GRUNEWALD J., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38–46.10.1002/art.21575
Search in Google Scholar Back to article
15. KLARESKOG L., RONNELID J., LUNDBERG K., PADYUKOV L., ALFREDSSON L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol. 2008;26:651–75.10.1146/annurev.immunol.26.021607.090244
Search in Google Scholar Back to article
16. RUIZ-ESQUIDE V., GOMARA MJ., PEINADO VI., GOMEZ PUERTA JA., BARBERA JA., CANETE JDE D., et al. Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clin Rheumatol. 2012;31(7):1047–50.10.1007/s10067-012-1971-y
Search in Google Scholar Back to article
17. PABST R., GEHRKE I. Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans? Am J Respir Cell Mol Biol. 1990;3(2):131–5.10.1165/ajrcmb/3.2.131
Search in Google Scholar Back to article
18. PABST R. Is BALT a major component of the human lung immune system? Immunol Today. 1992;13(4):119–22.10.1016/0167-5699(92)90106-H
Search in Google Scholar Back to article
19. RANGEL-MORENO J., HARTSON L., NAVARRO C., GAXIOLA M., SELMAN M., RANDALL TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest. 2006;116(12):3183–94.10.1172/JCI28756167882017143328
Search in Google Scholar Back to article
20. BAKA Z., GYORGY B., GEHER P., BUZAS EI., FALUS A., NAGY G. Citrullination under physiological and pathological conditions. Joint Bone Spine. 2012;79(5):431–6.10.1016/j.jbspin.2012.01.00822366145
Search in Google Scholar Back to article
21. KAWAHITO Y., ICHINOSE S., SANO H., TSUBOUCHI Y., KOHNO M., YOSHIKAWA T., et al. Mycoplasma fermentans glycolipid-antigen as a pathogen of rheumatoid arthritis. Biochem Biophys Res Commun. 2008;369(2):561–6.10.1016/j.bbrc.2008.02.07918307980
Search in Google Scholar Back to article

Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren’s syndrome

Abstract

Paradigm

My account